NECSTGEN BV
Desconocido
Penphomet: PEN photoporation for the genetic engineering of therapeutic mesenchymal stromal cells and T cells
NETHERLANDS CENTER FOR THE CLINICAL ADVANCEMENT OF STEM CELL GENE THERAPIES BV
participó en un
HORIZON EUROPE:
HORIZON-EIC-2023-TRANSITION-01
Adoptive cell therapy has emerged as a promising strategy to treat cancer. It relies on patient-derived cells, such as T cells and mesenchym...
2024-02-26 - 2027-02-28 | Financiado
2024-02-26 - 2027-02-28 | Financiado
BioProS: Biointelligent Production Sensor to Measure Viral Activity
NETHERLANDS CENTER FOR THE CLINICAL ADVANCEMENT OF STEM CELL GENE THERAPIES BV
participó en un
HORIZON EUROPE:
HORIZON-CL4-2021-DIGITAL-EMERGING-01
We aim to transform virus biomanufacturing processes and enable new quality control strategies by a continuous, real-time capable biohybrid...
2022-06-23 - 2026-06-30 | Financiado
2022-06-23 - 2026-06-30 | Financiado
* No se disponen de datos de la empresa actual.